News

Filter

Current filters:

Testosterone

1 to 9 of 712 results

FDA adding general warning to testosterone products potential for venous blood clots

FDA adding general warning to testosterone products potential for venous blood clots

22-06-2014

The US Food and Drug Administration is requiring manufacturers to include a general warning in the drug…

Men's HealthPharmaceuticalRegulationTestosteroneUSA

FDA investigating risk of stroke, heart attack and death with testosterone products

FDA investigating risk of stroke, heart attack and death with testosterone products

03-02-2014

The US Food and Drug Administration said on Friday that it is investigating the risk of stroke, heart…

AbbVieActavisAndrodermAndroGelAxironEli LillyMen's HealthNorth AmericaPharmaceuticalRegulationResearchTestosteroneUSA

Endo Pharma gets CTL from FDA relating to testosterone drug Aveed

31-05-2013

response letter (CRL) regarding the New Drug Application (NDA) for subsidiary Endo Pharmaceuticals' long-acting…

AveedEndo Health SolutionsEndo PharmaceuticalsMen's HealthNorth AmericaPharmaceuticalRegulationTestosterone

ProStrakan’s Sancuso out-licensed by Solasia in Asia

04-03-2010

UK specialty pharmaceutical firm ProStrakan says that Solasia Pharma, the group’s partner for Sancuso…

Asia-PacificGranisetronGranisetron Transdermal SystemKyowa HakkoKytrilLicensingNeurologicalPharmaceuticalSancusoTestosteronetransdermal

Alvogen acquires R&D capabilities and enters into multi-product development deal with Par Pharmaceutical

23-10-2009

New Jersey, USA-based Alvogen Group says that it has acquired R&D capabilities from Par Pharmaceutical.…

FinancialGenericsNorth AmericaTestosteronetransdermal

1 to 9 of 712 results

COMPANY SPOTLIGHT

Menarini

Back to top